AstraZeneca Plans Rs 250 Crore Investment for Chennai GCC Expansion

AstraZeneca India Private Limited (AZIPL), the Global Capability Centre of pharmaceutical giant AstraZeneca, announced on July 4 that it will be investing Rs 250 crore ($30 million) to expand its operations in Chennai.

"This investment aims to grow our Global Innovation and Technology Centre (GITC) in Chennai," the company revealed. "The expansion will create nearly 1,300 new roles dedicated to fostering innovation, boosting efficiency, and optimizing global operations."

Tamil Nadu Industries Minister TRB Rajaa expressed his excitement about the expansion, stating, "We are delighted to see AstraZeneca enhancing their capabilities by leveraging the vast talent pool in Tamil Nadu. Their commitment to reinvest and expand in our state is a strong validation of our people, talent, and supportive policies."

He further emphasized, "The swift uptake of office spaces in Chennai highlights Tamil Nadu's status as the Knowledge Capital of India."